Literature DB >> 23105496

Alterations of serum cholesterol and serum lipoprotein in breast cancer of women.

Kiran Hasija1, Hardeep K Bagga.   

Abstract

Fasting blood sample of 50 normal subjects (control) and 100 patients of breast cancer were investigated for serum total cholesterol, high density lipoprotein cholesterol, low density lipoprotein cholesterol, very low density lipoprotein, high density lipoprotein cholesterol:low density lipoprotein cholesterol ratio and total cholesterol:high density lipoprotein cholesterol ratio during breast cancer of women. Five cancer stages, types, age groups, parity and menopausal status were undertaken for the study. It was observed that there was a significant rise in serum total cholesterol and low density lipoprotein cholesterol whereas high density lipoprotein cholesterol and very low density lipoprotein cholesterol were not significant. The ratio of high density lipoprotein cholesterol:low density lipoprotein cholesterol and total cholesterol:high density lipoprotein cholesterol values increased significantly in breast cancer patients.

Entities:  

Keywords:  Breast cancer; cholesterol; lipoprotein profile

Year:  2005        PMID: 23105496      PMCID: PMC3454168          DOI: 10.1007/BF02893044

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  19 in total

1.  Lipoprotein alterations, abdominal fat distribution and breast cancer.

Authors:  L E Schreier; G A Berg; F M Basilio; G I Lopez; A E Etkin; R L Wikinski
Journal:  Biochem Mol Biol Int       Date:  1999-04

2.  Breast cancer risk in relation to serum cholesterol, serum beta-lipoprotein, height, weight, and blood pressure.

Authors:  S A Törnberg; L E Holm; J M Carstensen
Journal:  Acta Oncol       Date:  1988       Impact factor: 4.089

3.  Evidence of association between plasma high-density lipoprotein cholesterol and risk factors for breast cancer.

Authors:  N F Boyd; V McGuire
Journal:  J Natl Cancer Inst       Date:  1990-03-21       Impact factor: 13.506

4.  Effect of cancer treatment modalities on serum lipids and lipoproteins among women with carcinoma of the breast.

Authors:  A Ray; D Jain; R Yadav; S L Naik; S Sharma; A K Bahadur; B K Sharma
Journal:  Indian J Physiol Pharmacol       Date:  2001-07

Review 5.  Mammographic parenchymal pattern and breast cancer risk: a critical appraisal of the evidence.

Authors:  P J Goodwin; N F Boyd
Journal:  Am J Epidemiol       Date:  1988-06       Impact factor: 4.897

6.  Association between estradiol, estrogen receptors, total lipids, triglycerides, and cholesterol in patients with benign and malignant breast tumors.

Authors:  E A Mady
Journal:  J Steroid Biochem Mol Biol       Date:  2000-12-31       Impact factor: 4.292

7.  Serum lipids and breast cancer risk: a cohort study of 5,207 Danish women.

Authors:  A P Høyer; G Engholm
Journal:  Cancer Causes Control       Date:  1992-09       Impact factor: 2.506

8.  Increased serum concentrations of cholesterol and triglycerides in the progression of breast cancer.

Authors:  C C Zielinski; I Stuller; P Rausch; C Müller
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

9.  Studies on the changes in plasma lipids and lipoproteins in patients with benign and malignant breast cancer.

Authors:  K Kumar; P Sachdanandam; R Arivazhagan
Journal:  Biochem Int       Date:  1991-02

10.  Plasma lipids and prolactin in patients with breast cancer.

Authors:  I A Bani; C M Williams; P S Boulter; J W Dickerson
Journal:  Br J Cancer       Date:  1986-09       Impact factor: 7.640

View more
  15 in total

1.  Serum total PSA and free PSA in breast tumors.

Authors:  Prakruti Dash; Sanghamitra Pati; Manaswini Mangaraj; Pratima Kumari Sahu; Prakash Chandra Mohapatra
Journal:  Indian J Clin Biochem       Date:  2011-02-04

2.  Oxidant/antioxidant status, lipids and hormonal profile in overweight women with breast cancer.

Authors:  Naima Badid; Fatima Zohra Baba Ahmed; Hafida Merzouk; Slimane Belbraouet; Nassima Mokhtari; Sid Ahmed Merzouk; Riad Benhabib; Djalloul Hamzaoui; Michel Narce
Journal:  Pathol Oncol Res       Date:  2010-06       Impact factor: 3.201

Review 3.  Clinically Relevant Physical Benefits of Exercise Interventions in Breast Cancer Survivors.

Authors:  Amy A Kirkham; Kelcey A Bland; Sarah Sayyari; Kristin L Campbell; Margot K Davis
Journal:  Curr Oncol Rep       Date:  2016-02       Impact factor: 5.075

4.  The role of developing breast cancer in alteration of serum lipid profile.

Authors:  Kamal Eldin A Abdelsalam; Ikhlas K Hassan; Isam A Sadig
Journal:  J Res Med Sci       Date:  2012-06       Impact factor: 1.852

5.  Affinity of estrogens for human progesterone receptor A and B monomers and risk of breast cancer: a comparative molecular modeling study.

Authors:  Tarique N Hasan; Leena Grace B; Tariq A Masoodi; Gowhar Shafi; Ali A Alshatwi; P Sivashanmugham
Journal:  Adv Appl Bioinform Chem       Date:  2011-03-08

6.  Comparison of Serum Lipid Profiles between Normal Controls and Breast Cancer Patients.

Authors:  Pikul Laisupasin; Warayupa Thompat; Saowakon Sukarayodhin; Adisak Sornprom; Yuttana Sudjaroen
Journal:  J Lab Physicians       Date:  2013-01

7.  Mass spectrometry-based quantitative metabolomics revealed a distinct lipid profile in breast cancer patients.

Authors:  Yunping Qiu; Bingsen Zhou; Mingming Su; Sarah Baxter; Xiaojiao Zheng; Xueqing Zhao; Yun Yen; Wei Jia
Journal:  Int J Mol Sci       Date:  2013-04-12       Impact factor: 5.923

Review 8.  Exercise Prevention of Cardiovascular Disease in Breast Cancer Survivors.

Authors:  Amy A Kirkham; Margot K Davis
Journal:  J Oncol       Date:  2015-08-03       Impact factor: 4.375

9.  Protective Effect of Piper aduncum Capsule on DMBA-induced Breast Cancer in Rats.

Authors:  J Arroyo-Acevedo; R J Chávez-Asmat; A Anampa-Guzmán; R Donaires; José Ráez-Gonzáles
Journal:  Breast Cancer (Auckl)       Date:  2015-06-29

10.  Plasma level of LDL-cholesterol at diagnosis is a predictor factor of breast tumor progression.

Authors:  Catarina Rodrigues Dos Santos; Isabel Fonseca; Sérgio Dias; J C Mendes de Almeida
Journal:  BMC Cancer       Date:  2014-02-26       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.